Delivery Order SPE2DB22D1202-SPE2DB25FUZG4

Award Date 5/5/25
Potential Completion Date 5/6/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,118.64 firm fixed-price delivery order is for the supply of 4,566,790,127 dextroamphetamine-amphetamine 10 mg capsules. The contract has an ultimate completion date of December 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,506.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FYAH3) for the supply of 4,568,055,092 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,888.87, is for the delivery of 4,562,349,164 units of dextroamphetamine-amphetamine 10 mg capsules. This is a firm fixed-price delivery order contract with an ultimate completion date of October 2, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
The U.S. Defense Logistics Agency (DLA) awarded a $2,497.70 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,564,466,189 units of the drug dextroamphetamine-amphetamine ER 10 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,776,079 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules. The $1,126.92 firm fixed-price contract has a completion date of December 23, 2024. It is not designated as a set-aside contract. This award appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, solicited and awarded by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.86 firm-fixed-price delivery order contract covers the provision of 4,566,975,300 units of dextroamphetamine-amphetamine 10 mg tablets. The contract has an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $2,373.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,076,029 units of the prescription medication Dextroamphetamine-Amphetamine 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,724,223 dextroamphetamine 20 mg tablets in packages of 30. The fixed-price delivery order, valued at $1,080.66, has a completion date of September 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,480.78 firm-fixed-price delivery order is for the supply of 4,566,111,129 units of the drug Dextroamphetamine-Amphetamine 25 mg capsules. The contract has an ultimate completion date of October 16, 2024 and was awarded on October 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,558,601,061 units of Dextroamphetamine-Amphetamine 10 mg tablets in 100-count bottles. The award, valued at $1,184.59, is a firm fixed-price delivery order contract with a completion date of September 26, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUZG4
    Delivery Order

This federal contract award, valued at $2,127.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,143,281 units of Dextroamphetamine-Amphetamine 10 mg capsules. The contract is a Firm Fixed Price Delivery Order with a completion date of May 6, 2025. No set-aside designation was used for this award.

Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/4/25, 9:52 AM